Clinical Trials Browser

Phase 2 × Nasopharyngeal Neoplasms × 90 days × Clear all

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT03074513 2026-03-11

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

DermatologicEndocrineHead & NeckOther solid neoplasmThoracic

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

Clinical Trials

SG-AAA-II-01

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors